Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Snynf crawled date : 2021 - 09 - 29 save search
New England Journal of Medicine Publishes Positive Phase 3 Trial Results for REGEN-COV™ (casirivimab and imdevimab) to Treat COVID-19
Published: 2021-09-29 (Crawled : 21:00) - prnewswire.com
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -0.02%
H: 0.2%
C: -0.31%
REGN | News | $912.99 0.63% 34K
|
Health Technology
|
| O: 0.17%
H: 0.96%
C: -0.42%
covid positive results casirivimab phase 3 trial trial results
Breckenridge Announces Approval of its ANDA for Teriflunomide Tablets (generic for Aubagio®)
Published: 2021-09-29 (Crawled : 18:00) - biospace.com/
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
approval
IDWeek Presentations Highlight Continued Response to COVID-19
Published: 2021-09-29 (Crawled : 18:00) - biospace.com/
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 0.33%
H: 5.54%
C: -0.81%
covid presentation response covid-19
Expansion Therapeutics Widens Funding by $80 Million for RNA-Linked Research
Published: 2021-09-29 (Crawled : 17:00) - biospace.com/
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
funding expansion research
Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor SAR443820/DNL788 at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting
Published: 2021-09-29 (Crawled : 13:15) - globenewswire.com
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
DNLI | $16.105 -0.03% 11K
|
Health Technology
|
| O: 0.22%
H: 0.73%
C: -2.43%
presentation sclerosis
Janssen Showcases Recent Data in Relapsing Multiple Sclerosis at the 2021 European Committee for Treatment and Research in Multiple Sclerosis Congress
Published: 2021-09-29 (Crawled : 12:00) - prnewswire.com
JNJ | News | $147.07 -1.67% 890K
|
Health Technology
|
| O: 0.12%
H: 1.02%
C: 0.63%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
multiple sclerosis treatment europe sclerosis research
Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
Published: 2021-09-29 (Crawled : 12:00) - biospace.com/
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
disease neurodegenerative expansion
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
CZOO | $9.98 100.0% 330K
|
AMST | $3.48 74.0% 21M
|
Technology Services
BOF | $1.78 52.14% 15M
|
SYRA | $1.5 51.23% 1M
|
n/a
CSSE 4 | $0.2184 43.4% 36M
|
Consumer Services
RILY | $30.325 39.62% 6.8M
|
Finance
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.445 26.19% 980K
|
Information
RBBN 4 | $3.21 24.9% 580K
|
Electronic Technology
LICN | $0.6987 24.77% 4.4M
|
Your saved searches
Save your searches and get alerts when important news are released.